
Progyny (PGNY) Stock Forecast & Price Target
Progyny (PGNY) Analyst Ratings
Bulls say
Progyny is a financially strong company with a unique and comprehensive approach in the fertility benefits space, leading to strong growth and profitability. They prioritize customer satisfaction and early renewal, and have a diverse range of clients, giving them confidence in their long-term growth. While there are potential risks and delays in new revenue generation, Progyny's positive earnings for 1Q and ongoing efforts to reach a wider audience through marketing newer services bode well for their future prospects.
Bears say
Progyny is facing significant challenges as it operates in a highly competitive market for fertility benefits solutions. While the company has a strong attachment rate and is able to reduce costs and improve outcomes through integration with the clinical workflow, there are concerns around alternative medication channels and fragmentation of benefits. Additionally, with only 2.5% of US births resulting from assisted reproductive technology, adoption of fertility coverage still has a long runway. Furthermore, the company's reliance on utilization for annual performance makes it vulnerable to fluctuations in human behavior.
This aggregate rating is based on analysts' research of Progyny and is not a guaranteed prediction by Public.com or investment advice.
Progyny (PGNY) Analyst Forecast & Price Prediction
Start investing in Progyny (PGNY)
Order type
Buy in
Order amount
Est. shares
0 shares